Brain Metabolic Correlates of Decision Making in Amnestic Mild Cognitive Impairment

Abstract Persons with amnestic mild cognitive impairment (MCI) have subtle impairments in medical decision-making capacity (MDC). We examined the relationship between proton magnetic resonance spectroscopy (MRS) and MDC in MCI. Twenty-nine MCI patients and 42 controls underwent MRS to obtain ratios of N-acetylaspartate (NAA)/Creatine (Cr), Choline (Cho)/Cr, and myo-Inositol (mI)/Cr of the posterior cingulate. They also completed the Capacity to Consent to Treatment Instrument (CCTI), a vignette-based instrument measuring decisional standards of expressing choice, appreciating consequences of choice, providing rational reasons for choice, and understanding treatment choices. Patients showed abnormal MRS ratios of mI/Cr and Cho/Cr compared to controls, and impairments on the CCTI understanding and reasoning Standards. Performance on the reasoning standard of the CCTI was correlated with NAA/Cr (r = .46, p < .05). The relationship of NAA/Cr with decision-making suggests a role for posterior cortical neuronal functioning in performance of complex IADLs in MCI.

[1]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[2]  D. G. Clark,et al.  Brain Proton MRS is Correlated with Financial Abilities in Patients with Alzheimer’s Disease , 2007, Brain Imaging and Behavior.

[3]  P Sachdev,et al.  Magnetic resonance spectroscopy in AD , 2001, Neurology.

[4]  L. Harrell,et al.  Assessing the competency of patients with Alzheimer's disease under different legal standards. A prototype instrument. , 1995, Archives of neurology.

[5]  R. Raman,et al.  Medical decision-making capacity in mild cognitive impairment , 2008, Neurology.

[6]  Clifford R Jack,et al.  1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease , 2002, Journal of the International Neuropsychological Society.

[7]  M N Rossor,et al.  MRS shows abnormalities before symptoms in familial Alzheimer disease , 2006, Neurology.

[8]  L. Harrell,et al.  Amnestic mild cognitive impairment: Diagnostic outcomes and clinical prediction over a two-year time period , 2006, Journal of the International Neuropsychological Society.

[9]  D. Pandya,et al.  Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns , 1999, The European journal of neuroscience.

[10]  Impaired financial abilities in mild cognitive impairment , 2003, Neurology.

[11]  N. Fayed,et al.  Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. , 2005, The American journal of psychiatry.

[12]  C. Jack,et al.  Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. , 2003, AJNR. American journal of neuroradiology.

[13]  L. Harrell,et al.  Declining medical decision-making capacity in mild AD: a two-year longitudinal study. , 2006, Behavioral sciences & the law.

[14]  P. Antuono,et al.  Decreased glutamate + glutamine in Alzheimer’s disease detected in vivo with 1H-MRS at 0.5 T , 2001, Neurology.

[15]  O Almkvist,et al.  Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment , 2001, Neuroreport.

[16]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[17]  L. Harrell,et al.  Competency to consent to medical treatment in cognitively impaired patients with Parkinson’s disease , 2000, Neurology.

[18]  H. Lamb,et al.  Reproducibility of Human Cardiac 31P‐NMR Spectroscopy , 1996, NMR in biomedicine.

[19]  O. Okonkwo,et al.  Executive function is associated with brain proton magnetic resonance spectroscopy in amnestic mild cognitive impairment , 2007, Journal of clinical and experimental neuropsychology.

[20]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[21]  Stephanie T. Lanza,et al.  Medical decision-making capacity in patients with mild cognitive impairment , 2007, Neurology.

[22]  Clifford R. Jack,et al.  Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease , 2007, Neurobiology of Aging.

[23]  Seong Jin Cho,et al.  Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease , 2008, NeuroImage.

[24]  J. Hodges,et al.  Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment , 2003, Annals of neurology.

[25]  H. Braak,et al.  Alzheimer Neuropathology and Limbic Circuits , 1993 .

[26]  F Mauguiere,et al.  The duality of the cingulate gyrus in monkey. Neuroanatomical study and functional hypothesis. , 1980, Brain : a journal of neurology.

[27]  R. Raman,et al.  Cognitive models of medical decision-making capacity in patients with mild cognitive impairment , 2008, Journal of the International Neuropsychological Society.

[28]  Y. Stern,et al.  Functional deficits in patients with mild cognitive impairment: Prediction of AD , 2002, Neurology.

[29]  E. Tangalos,et al.  CME Practice parameter: , 2022 .